These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 29017953)

  • 1. In vitro and in vivo study of pH-sensitive and colon-targeting P(LE-IA-MEG) hydrogel microspheres used for ulcerative colitis therapy.
    Shi X; Yan Y; Wang P; Sun Y; Zhang D; Zou Y; Hu S; Zhang L; Xing J; Dong Y
    Eur J Pharm Biopharm; 2018 Jan; 122():70-77. PubMed ID: 29017953
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo application of pH-sensitive colon-targeting polysaccharide hydrogel used for ulcerative colitis therapy.
    You YC; Dong LY; Dong K; Xu W; Yan Y; Zhang L; Wang K; Xing FJ
    Carbohydr Polym; 2015 Oct; 130():243-53. PubMed ID: 26076623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Improvement of side-effects and treatment on the experimental colitis in mice of a resin microcapsule-loading hydrocortisone sodium succinate.
    Dong K; Zhang H; Yan Y; Sun J; Dong Y; Wang K; Zhang L; Shi X; Xing J
    Drug Dev Ind Pharm; 2017 Mar; 43(3):448-457. PubMed ID: 27819157
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Assessment of the drug loading, in vitro and in vivo release behavior of novel pH-sensitive hydrogel.
    Dong K; Dong Y; You C; Xu W; Huang X; Yan Y; Zhang L; Wang K; Xing J
    Drug Deliv; 2016; 23(1):174-84. PubMed ID: 24806351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Novel pH-sensitive hydrogels for 5-aminosalicylic acid colon targeting delivery: in vivo study with ulcerative colitis targeting therapy in mice.
    Bai XY; Yan Y; Wang L; Zhao LG; Wang K
    Drug Deliv; 2016 Jul; 23(6):1926-32. PubMed ID: 25693641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Colon targeted oral drug delivery system based on alginate-chitosan microspheres loaded with icariin in the treatment of ulcerative colitis.
    Wang QS; Wang GF; Zhou J; Gao LN; Cui YL
    Int J Pharm; 2016 Dec; 515(1-2):176-185. PubMed ID: 27713029
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral Core-Shell Nanoparticles Embedded in Hydrogel Microspheres for the Efficient Site-Specific Delivery of Magnolol and Enhanced Antiulcerative Colitis Therapy.
    Wang X; Gu H; Zhang H; Xian J; Li J; Fu C; Zhang C; Zhang J
    ACS Appl Mater Interfaces; 2021 Jul; 13(29):33948-33961. PubMed ID: 34261306
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Colon-Targeted Therapy of Tacrolimus (FK506) in the Treatment of Experimentally Induced Colitis.
    Ali AS; Altayari AA; Khan LM; Alharthi SE; Ahmed OA; El-Shitany NA; Ali SS; Saadah OI
    Pharmacology; 2020; 105(9-10):541-549. PubMed ID: 31940656
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Research on Preparation of 5-ASA Colon-Specific Hydrogel Delivery System without Crosslinking Agent by Mechanochemical Method.
    Xu W; Su W; Xue Z; Pu F; Xie Z; Jin K; Polyakov NE; Dushkin AV; Su W
    Pharm Res; 2021 Apr; 38(4):693-706. PubMed ID: 33754258
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Oral alginate microspheres for the efficient site-specific delivery of epidermal growth factor attenuated murine ulcerative colitis via repairing the mucosal barrier.
    Chen B; Li D; Tong B; Wang L; Lin H; Xu H; Hu S
    Int J Pharm; 2024 Aug; 661():124394. PubMed ID: 38944169
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Novel biodegradable pH-sensitive hydrogels: An efficient controlled release system to manage ulcerative colitis.
    Abbasi M; Sohail M; Minhas MU; Khan S; Hussain Z; Mahmood A; Shah SA; Kousar M
    Int J Biol Macromol; 2019 Sep; 136():83-96. PubMed ID: 31195039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bumadizone calcium dihydrate microspheres compressed tablets for colon targeting: formulation, optimization and in vivo evaluation in rabbits.
    Nour SA; Abdelmalak NS; Naguib MJ
    Drug Deliv; 2015 May; 22(3):286-97. PubMed ID: 24601826
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Preparation and in vitro/in vivo evaluation of dextran matrix tablets of budesonide in experimental ulcerative colitis in rats.
    Ahmadi F; Varshosaz J; Emami J; Tavakoli N; Minaiyan M; Mahzouni P; Dorkoosh F
    Drug Deliv; 2011 Feb; 18(2):122-30. PubMed ID: 20954795
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Oral administration of pH-sensitive curcumin-loaded microparticles for ulcerative colitis therapy.
    Xiao B; Si X; Zhang M; Merlin D
    Colloids Surf B Biointerfaces; 2015 Nov; 135():379-385. PubMed ID: 26275840
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and characterization of colon specific drug delivery system bearing 5-ASA and Camylofine dihydrochloride for the treatment of ulcerative colitis.
    Dubey R; Dubey R; Omrey P; Vyas SP; Jain SK
    J Drug Target; 2010 Sep; 18(8):589-601. PubMed ID: 20088681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beneficial anti-inflammatory effect of paeonol self-microemulsion-loaded colon-specific capsules on experimental ulcerative colitis rats.
    Zong S; Pu Y; Li S; Xu B; Zhang Y; Zhang T; Wang B
    Artif Cells Nanomed Biotechnol; 2018; 46(sup1):324-335. PubMed ID: 29316822
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mesalazine-probiotics beads for acetic acid experimental colitis: formulation and characterization of a promising new therapeutic strategy for ulcerative colitis.
    Vishwakarma N; Ganeshpurkar A; Pandey V; Dubey N; Bansal D
    Drug Deliv; 2015 Jan; 22(1):94-9. PubMed ID: 24491122
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mucoadhesive nanoparticles-based oral drug delivery systems enhance ameliorative effects of low molecular weight heparin on experimental colitis.
    Yan Y; Sun Y; Wang P; Zhang R; Huo C; Gao T; Song C; Xing J; Dong Y
    Carbohydr Polym; 2020 Oct; 246():116660. PubMed ID: 32747292
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Synthesis and evaluation of dextran-budesonide conjugates as colon specific prodrugs for treatment of ulcerative colitis.
    Varshosaz J; Emami J; Tavakoli N; Fassihi A; Minaiyan M; Ahmadi F; Dorkoosh F
    Int J Pharm; 2009 Jan; 365(1-2):69-76. PubMed ID: 18804521
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Drug release in vivo and efficacy evaluation of a new colon targeted powder of total saponins of Pulsatilla.
    Chen Z; Zhao T; Zhou L; Kang J; Guan Y; Yang M; Yang S; Liu H
    Biomed Pharmacother; 2020 Sep; 129():110376. PubMed ID: 32563985
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.